BMJ Group Logo

Third of UK government’s nutrition advisors still paid by food companies including Coca Cola and Nestlé

Financial conflicts of interest still rife, despite new rules banning such links Public health experts say conflicts should be removed ‘immediately’ Nearly a third of the government’s nutrition advisors still have “significant” ties to the food industry including Coca Cola, Sainsbury’s, and Danone, reveals a new analysis by The ...

2026-09-10T09:36:59+01:0010 September 2026|Press release, The BMJ|

Eminent cardiologist involved in treatment guidelines received £50m from drug research contracts

Eminent cardiologist involved in treatment guidelines received £50m from drug research contracts Case shows what’s at stake in the debate around transparency of doctor-industry relations A British cardiologist and former president of the European Society of Cardiology (ESC) has been judged by the ESC to have committed severe misconduct ...

2026-09-02T09:27:51+01:0027 August 2026|Press release, The BMJ|

At least 1 in 4 former NFL players who died during 2016-21 had evidence of brain disease at death linked to repeated head impacts

New estimates strengthen evidence of confirmed CTE burden in former NFL players, while highlighting uncertainties   At minimum, nearly a quarter of all former National Football League (NFL) players who died from 2016 to 2021 had confirmed chronic traumatic encephalopathy (CTE) – a neurodegenerative disease linked to repeated head impacts  – ...

2026-09-03T15:53:54+01:0025 August 2026|Press release, The BMJ|

Four fifths of NHS trusts still using pen and paper for record keeping

A paper-free NHS remains a distant reality, suggests BMJ analysis Twenty-five years after the government's first push to digitise the NHS, an investigation by The BMJ reveals that only about a fifth of hospital trusts in England are using fully electronic systems for clinical record-keeping. Responses to freedom of information (FOI) requests show that just 39 ...

2026-08-05T16:24:42+01:006 August 2026|Press release, The BMJ|

GLP-1 drug linked to heart benefits for high-risk patients

Findings from clinical practice will help inform shared decision making Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds ...

2026-08-05T16:21:54+01:006 August 2026|Press release, The BMJ|
Go to Top